Winton Group LTD Ligand Pharmaceuticals Inc Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$89.56 - $126.72 $2.03 Million - $2.87 Million	-22,628 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$68.28 - $123.65 $979,954 - $1.77 Million	-14,352 Reduced 38.81%	22,628 $2.53 Million
Q1 2020 May 11, 2020	BUY	$63.37 - $107.88 $306,584 - $521,923	4,838 Added 15.05%	36,980 $2.69 Million
Q4 2019 Feb 13, 2020	BUY	$96.94 - $113.59 $1.46 Million - $1.71 Million	15,078 Added 88.36%	32,142 $3.35 Million
Q3 2019 Nov 08, 2019	BUY	$86.25 - $120.16 $1.47 Million - $2.05 Million	17,064 New	17,064 $1.7 Million
Q2 2018 Aug 20, 2018	SELL	$150.77 - $207.98 $1.06 Million - $1.46 Million	-7,011 Closed	0 $0
Q1 2018 May 21, 2018	BUY	$138.63 - $182.62 $971,934 - $1.28 Million	7,011 New	7,011 $0

262

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.99B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.